Skip Nav Destination
1-20 of 76
Keywords: Quality of lifeClose
Dermatology (2023) 239 (6): 1007–1012.
Published Online: 16 September 2023
... and itch and further our understanding of how pain and itch impact quality of life (QoL) in patients with HS. Objective: The objective of the study was to determine factors associated with pain severity, itch severity, and reduced QoL in patients with HS. Methods: This is a retrospective cross-sectional...
Manuel Schuermann, Clara Richter, Matteo Tanadini, Klaus Steigmiller, Elias Burri, Carole Guillet, Isabelle Luchsinger, Barbara Meier-Schiesser, Andrea Boesch, Mirjam Nägeli, Jürg Hafner
Dermatology (2023) 239 (6): 996–1006.
Published Online: 06 September 2023
...Manuel Schuermann; Clara Richter; Matteo Tanadini; Klaus Steigmiller; Elias Burri; Carole Guillet; Isabelle Luchsinger; Barbara Meier-Schiesser; Andrea Boesch; Mirjam Nägeli; Jürg Hafner Background: Chronic prurigo (CPG) presents with pruriginous lesions and reduced quality of life (QoL...
Dermatology (2023) 239 (4): 601–608.
Published Online: 08 August 2023
...Manuel Sánchez-Díaz; Maria Carmen Salazar-Nievas; Alejandro Molina-Leyva; Salvador Arias-Santiago Background: Chronic spontaneous urticaria (CSU) has been associated with poor quality of life and mood disturbances. However, factors associated with these dimensions have not been properly assessed...
April W. Armstrong, Barbra Bohannan, Sicily Mburu, Laura C. Coates, Alexis Ogdie, Ivette Alarcon, Torben Kasparek, Susan Frade, Silvia Fernandez Barrio, Matthias Augustin
Dermatology (2023) 239 (4): 621–634.
Published Online: 08 August 2023
... (PEST), indicative of potential PsA. Overall, 48% of patients reported that their disease had a very large to extremely large effect on quality of life (QoL; Dermatology Life Quality Index [DLQI] score, 11–30); only 13% of patients reported no impact of the disease on QoL (DLQI, 0–1). Most patients had...
Clara Richter, Jürg Hafner, Manuel Schuermann, Matteo Tanadini, Nisia Trisconi, Peter Schmid-Grendelmeier, Thomas Kündig, Mirjam Nägeli, Marie-Charlotte Brüggen, Carole Guillet
Dermatology (2023) 239 (5): 811–817.
Published Online: 27 June 2023
.... It reduces patients’ quality of life (QoL). Dupilumab is a monoclonal human IgG antibody that inhibits signaling of the interleukin 4 (IL-4) and interleukin 13 (IL-13) pathways through blockade of the IL-4 receptor. Patients with CPG who receive dupilumab often report great improvement in itch and overall...
Dermatology (2023) 239 (3): 494–498.
Published Online: 13 June 2023
...Amaris N. Geisler; Jonathan Koptyev; Andrew Strunk; Pooja R. Shah; Amit Garg Background: Vulvar lichen sclerosus (VLS) is a chronic, relapsing, inflammatory dermatosis that has significant impact on patients’ quality of life (QoL). While disease severity and associated QoL impact have been studied...
Aslı Bilgic, Bilge Fettahlıoglu Karaman, Duriye Deniz Demirseren, Levent Cınar, Nida Kacar, Aylin Türel Ermertcan, Emel Bulbul Baskan, Münevver Güven, Serkan Yazici, Tugba Özkök Akbulut, Derya Ucmak, Arzu Ataseven, Selami Aykut Temiz, Burhan Engin, Aysun Şikar Aktürk, Hayriye Sarıcaoğlu, Müge güler özden, Hilal özdemir, Kifayet Mammadli, Koray Durmaz, Fatmagül Gülbaşaran, Fadime Kılınc, Hatice Kaya Özden, Melis Gönülal, Didem Didar Balcı, Bengü Çevirgen Cemil, Sezgi Sarıkaya Solak, Leyla Baykal Selçuk, Göknur Özaydın Yavuz, İbrahim Halil Yavuz, Levent Dönmez, Erkan Alpsoy
Dermatology (2023) 239 (3): 445–453.
Published Online: 13 June 2023
... and all disease activity scores, quality of life measures, BDI-II, and VAS-pain scores. Obesity, family history, low education and income level, vulva/scrotum involvement and being actively treated are significant and independent predictive factors for high internalized stigma in multivariate analysis...
Subject Area:Topic Article Package: Antibody-Drug Conjugates , Dermatology , Immunology and Allergy
Dermatology (2023) 239 (3): 368–378.
Published Online: 13 June 2023
...Monica Corazza; Maria Elena Flacco; Natale Schettini; Alessandro Borghi Background: Quality of life (QoL) impairment by eczematous diseases, with reference to body site involvement, has not been deeply addressed. Objectives: The aims of this study were to assess: (1) the impact on QoL of eczematous...
Pavel V. Chernyshov, Francesca Sampogna, Christos C. Zouboulis, Michael J. Boffa, Servando E. Marron, Liana Manolache, Nives Pustišek, Vincenzo Bettoli, Dimitra Koumaki, Olha Chubar, Tetiana V. Pochynok, Dillon Mintoff, Nikolaos G. Bonitsis, Saskia Spillekom-van Koulil, Rieke J.B. Driessen, Andriy V. Chernyshov, Anthony Paul Bewley, Andrea W.M. Evers, Ivan P. Chernyshov, Lucia Tomas-Aragones
Dermatology (2023) 239 (2): 267–272.
Published Online: 10 March 2023
... V. Chernyshov; Anthony Paul Bewley; Andrea W.M. Evers; Ivan P. Chernyshov; Lucia Tomas-Aragones Background: Health-related quality of life (HRQoL) assessment in patients with acne is recommended by several national guidelines. There are several acne-specific HRQoL instruments. Objectives...
Alet J.G. Leus, Marjolijn S. Haisma, Jorrit B. Terra, Grigory Sidorenkov, Suzanne Festen, Boudewijn E.C. Plaat, György B. Halmos, Emoke Racz
Dermatology (2023) 239 (1): 148–157.
Published Online: 24 January 2023
... area (cSCCHN). Age, life expectancy, and frailty are not taken into consideration by current guidelines. Objectives: The objective of this study was to evaluate the influence of frailty and life expectancy on guideline deviation, treatment outcomes, and quality of life (QoL) after treatment in patients...
Dermatology (2022) 238 (5): 919–927.
Published Online: 06 September 2022
... is an effective and safe option for children with severe plaque psoriasis. Immunotherapy Pediatric dermatology Psoriasis Quality of life Approximately 30% of adult psoriasis develops in childhood [ 1 ]. The incidence of pediatric psoriasis increases with age, especially before the age of 7 years...
Dermatology (2022) 238 (6): 1120–1129.
Published Online: 30 May 2022
..., associated comorbidities, and health-related quality of life. Alexis.firstname.lastname@example.org 28 12 2021 24 04 2022 30 5 2022 © 2022 S. Karger AG, Basel 2022 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may...
Ugur Sahin, Kelly Reeve, Giulia Tochtermann, Kamilla Kilanowski, Alexander Navarini, Laurence Imhof, Ulrike Held, Günther F.L. Hofbauer
Dermatology (2022) 238 (6): 1050–1059.
Published Online: 09 May 2022
...Ugur Sahin; Kelly Reeve; Giulia Tochtermann; Kamilla Kilanowski; Alexander Navarini; Laurence Imhof; Ulrike Held; Günther F.L. Hofbauer Background: Improving health-related quality of life (HRQoL), disease severity, and treatment adherence through patient education is an increasingly important, yet...
Dermatology (2022) 238 (4): 807–810.
Published Online: 29 December 2021
... as it negatively impacts their quality of life (QoL). This displays the immense need for multidisciplinary collaboration to prevent and treat cetuximab-induced acneiform eruption (CIAE). Prevention methods include, but are not limited to, education, skin care routines, and prophylactic drugs. The following...
Dermatology (2022) 238 (4): 762–771.
Published Online: 20 December 2021
... influenced the personal impact of wound care routines on patients. Statistical significance was determined as p value <0.05. Results: In total , 908 people from 28 countries responded. Of these, 81% ( n = 734) reported that regular dressing changes negatively impacted on their quality of life. Most...
Fatma Jendoubi, Stefana Balica, Marie Aleth Richard, Christine Chiaverini, Claire Bernier, Nathalie Quiles, Herve Bachelez, Marie Beylot-Barry, Stéphanie Mallet, Catherine Goujon, Josiane Parier, Laurent Misery, Florence Carrere, Valérie Lauwers-Cances, Carle Paul, for the French Psoriasis Research Group
Dermatology (2022) 238 (4): 630–639.
Published Online: 09 December 2021
... Group Background: Psoriasis is a chronic inflammatory skin disease that has a profound effect on health-related quality of life (HRQoL). Patient education programmes may help patients to gain life-long control over their chronic disease. Objective: This multicentre randomised controlled study evaluated...
Gabriella Fabbrocini, Giulia Ruina, Giulia Giovanardi, Valentina Dini, Beatrice Raone, Marina Venturini, Raffaele Dante Caposiena Caro, Stefano Veraldi, Serafinella Patrizia Cannavò, Giulia Merlo, Alberto Maria Bertoldi, Federica Fiorentini, Elisa Molinelli, Laura Atzori, Maria Rita Bongiorno, Michele Lo Re, Nevena Skroza, Claudia Lasagni, Chiara Franchi, Marco Ardigò, Luisa Di Costanzo, Luca Stingeni, Paolo Amerio, Federica Sanna, Leonardo Pescitelli, Paolo Broganelli, Claudia De Cupis, Giuliana Gualberti, Valeria Saragaglia, Giuseppe Argenziano
Dermatology (2022) 238 (3): 487–497.
Published Online: 02 September 2021
... impact on patients’ quality of life (QoL). Objective: To evaluate how the burden of HS disease impacts on patient well-being and working activities in a large Italian population over a period of 9 months. Methods: A multicenter, prospective, epidemiologic cohort study was conducted in adult Italian...
Morgane Condamina, Laetitia Penso, Viet-Thi Tran, Claire Hotz, Philippe Guillem, Axel Patrice Villani, Pierre Perrot, Marie-France Bru, Eric Jacquet, Aude Nassif, Hervé Bachelez, Pierre Wolkenstein, Marie Beylot-Barry, Marie-Aleth Richard, Philippe Ravaud, Manuelle Viguier, Emilie Sbidian
Dermatology (2021) 237 (5): 748–758.
Published Online: 27 January 2021
... Background: Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition substantially impacting patients’ quality of life; the pathogenesis remains unclear, and treatment is complex and not yet standardized. Observational data are increasingly being used to evaluate therapeutics in “real-life...
M. Ingmar van Raath, Sandeep Chohan, Albert Wolkerstorfer, Chantal M.A.M. van der Horst, Jacqueline Limpens, Xuan Huang, Baoyue Ding, Gert Storm, René R.W.J. van der Hulst, Michal Heger
Dermatology (2021) 237 (3): 416–432.
Published Online: 03 December 2020
... included that reported on 6 physician-reported OMIs of clinical improvement and 6 parent- or patient-reported OMIs of life impact, of which 3 for health-related quality of life and 1 for perceived stigmatization. Overall, the quality of OMI development was inadequate (63%) or doubtful (37%). Each...
Dermatology (2021) 237 (4): 629–634.
Published Online: 17 September 2020
..., their effect on quality of life, and potential risk factors for skin cancer. Methods: Ninety-four participants were recruited from an Australian heart and lung transplant centre between March and December 2016. The participants were asked to fill out a questionnaire which included the Dermatology Life Quality...